Nortons Inc. is representing Aspen Pharmaceuticals (“Aspen”) and GlaxoSmithKline in relation to Aspen acquiring a portfolio of products from GlaxoSmithKline, in so far as they are sold to the “rest of the world”, excluding North America and Europe. The portfolio of products include Solpadeine, Phillips MOM, Zantac, Nytol, Cartia, Valad, Beconase, Dequadin, Borstol, Cofal, Hedex,.
Mergers & Acquisitions
Nortons Inc. is representing Tsogo Sun Holdings (Pty) Limited (“Tsogo Holdings”) in securing competition law approval in relation to the large merger between Tsogo Holdings and Gold Reef Resorts Limited (“Gold Reef”) which will see the parties merging their respective gaming and hotel businesses. The proposed merger will be effected through an acquisition by Gold.
Nortons Inc. represented Zhejiang Geely Holdings Group (“Geely”) in its US$1.8 billion acquisition of Volvo Cars from Ford Motors Co. in South Africa. Geely’s chairman described the deal as “a milestone” for both Geely and Volvo.
Nortons Inc. secured competition law approval for both Tsogo Sun Gaming and Millenium Casinos Limited (“Millenium”) in relation to the large merger between the two companies in terms of which Tsogo Sun Gaming acquired the entire issued share capital of Millenium from Johnnic Holdings Limited, a wholly owned subsidiary of Hosken Consolidated Investments Limited, a.
Nortons Inc. assisted both Tsogo Sun Gaming (Pty) Ltd (“Tsogo Sun Gaming”) and Century Casinos Incorporated (“Century Casinos”), the US based gaming company, in gaining unconditional approval from the South African Competition Tribunal for Tsogo Sun Gaming’s R490 million acquisition of Century Casino’s shares in Century Casinos Africa. The deal saw Century Casino selling substantial.
Nortons Inc. successfully represented both the Johannesburg Stock Exchange Ltd (“JSE”) and the Bond Exchange of South Africa (“BESA”) in the JSE’s R240.5 million acquisition of the entire ordinary share capital of BESA. Nortons Inc. managed to secure the approval of the large merger by the South African Competition Tribunal despite opposition from shareholders of.
Nortons Inc. represented both parties in obtaining unconditional approval from the South African Competition Tribunal in the large merger between TSB Sugar RSA Limited (“TSB”) and the business of Illovo Sugar Limited’s Pongola Mill. The transaction involved the acquisition by TSB of the entire business o Pongol Sugar Mill from Illovo which resulted in the.
Nortons Inc. secured unconditional competition law approval in South Africa for both Aspen Pharmacare and Fine Chemicals Corporation in Aspen’s acquisition of the remaining 50% interest in Fine Chemicals which it did not already own. Aspen is a public company listed on the Johannesburg Stock Exchange and is the largest manufacturer of genetic medicines in.
Nortons Inc. represented both Imperial Group (Pty) Ltd (“Imperial Group”) and Midas Group (Pty) Ltd (“Midas Group”) in successfully obtaining competition law approval from the South African Competition Tribunal on 21 September 2009 in relation to the large merger between the two companies. The transaction entailed the acquisition by Imperial Group of 56% of the.
Nortons Inc. represented both Merck & Co Incorporated (“Merck”), a global, research driven pharmaceutical corporation, and Schering-Plough Corporation (“Schering-Plough”), a global science-based health care company, in the much publicised acquisition (by way of reverse merger) by Schering-Plough of Merck in a cash and stock transaction valued at approximately US$41.1 billion.